Gujarat Kidney and Super Speciality Limited (GKSL) has announced the procurement of 100 AI-enabled haemodialysis machines, marking a significant expansion of its technology-driven renal care capabilities across Gujarat. The company has entered into an arrangement for the procurement of these units, with Phase-1 deployment of 8 machines scheduled at its Gujarat Multi Speciality Hospital, Godhra facility within the next 10 days. All required technical inspections have been completed successfully ahead of the rollout. The announcement was made under Regulation 30 and communicated to BSE Limited and the National Stock Exchange of India Limited, signed by Managing Director Dr. Praggnesh Bharpoda on 14 May 2026.

Phase-1 Deployment at Godhra Facility

The first phase of the rollout focuses on the Godhra facility, where 8 AI-based haemodialysis machines are to be installed and commissioned. Key highlights of the Phase-1 deployment are outlined below:

Trained clinical and technical teams are reported to be in place to operate the new platform from day one. The expanded session capacity is intended to enable GKSL to serve more patients from Godhra and adjoining districts, reducing the need for travel to tertiary care centres.

Why AI-Enabled Haemodialysis Matters

Unlike conventional dialysis equipment, AI-based haemodialysis machines continuously analyse intra-session data — including fluid balance, blood pressure trends, ultrafiltration response, and other clinical parameters — to support safer and more personalised treatment for each patient. The key clinical and operational benefits highlighted by the company include:

• Real-time decision support for nephrologists and dialysis technicians during each session
• Early detection of intradialytic complications such as hypotension and cramping
• Personalised treatment parameters adapted to each patient's clinical profile
• Improved consistency, traceability, and audit-readiness of every dialysis session

Network-Wide Rollout Plan

The remaining machines from the 100-unit procurement will be progressively deployed across GKSL's network of dialysis centres in a phased manner, in line with site readiness and clinical demand. The investment is intended to substantially scale up access to high-quality, technology-enabled renal care across Gujarat. The expansion aligns with the company's stated strategic objective of scaling up dialysis capacity and strengthening technology-enabled patient care across its network of healthcare facilities in the state.

Gujarat kidney and super speciality Limited successfully concluded its postal ballot process on 25-04-2026, with shareholders demonstrating strong support for the company's strategic initiatives. The e-voting process, which ran from 27th March 2026 to 25th April 2026, resulted in the approval of all three proposed resolutions with requisite majority support under Regulation 44 of SEBI (LODR) Regulations 2015.

Postal Ballot Results Overview

The company sought shareholder approval through remote e-voting on three critical resolutions. Mr. Dharmendra Bhaliya, Practising Company Secretary (C.P. No. 26448), served as the appointed Scrutinizer for the process conducted by MUFG Intime India Private Limited.

Resolution-wise Voting Results

Resolution 1: Healthcare Expansion Funding

The special resolution for interim utilisation of funds towards healthcare expansion received unanimous support from shareholders.

Resolution 2: Financial Statements Revision

The resolution for voluntary revision of financial statements and board's report under Section 131 of Companies Act 2013 received strong support, with minimal opposition.

Resolution 3: Secretarial Auditor Appointment

The ordinary resolution to appoint Mr. Dharmendra Bhaliya as Secretarial Auditor for FY 2025-26 was approved with strong majority support.

Shareholder Participation Analysis

The postal ballot witnessed significant participation across different shareholder categories. The company's total shareholding of 78,843,250 shares saw 56,846,254 votes being cast, representing 72.1003% participation in the e-voting process.

Regulatory Compliance and Process

The postal ballot process was conducted in strict adherence to regulatory requirements. The company published the postal ballot notice dated 19-03-2026 and ensured compliance with SEBI (LODR) Regulations 2015. The cut-off date for determining eligible shareholders was set as 20th March 2026, and the voting period extended for 30 days as mandated by regulations. The scrutinizer's report confirmed that all procedural requirements were met, including proper notification to stock exchanges BSE Limited and National Stock Exchange of India Limited.